BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-10.66%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$551M
AUM Growth
–
Cap. Flow
+$551M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.05%
Holding
130
New
130
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.1M |
| 3 |
Medtronic
MDT
|
$20.7M |
| 4 |
Biogen
BIIB
|
$19.9M |
| 5 |
Abbott
ABT
|
$16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Geron
GERN
$893M
| $131K | 0.02% | +45,000 | New | +$131K |
|
|
TTPH
127
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $102K | 0.02% | +22,000 | New | +$102K |
|
|
EIGR
128
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $56K | 0.01% | +3,333 | New | +$56K |
|
|
AST
129
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $9K | ﹤0.01% | +1,875 | New | +$9K |
|
|
BTX.WS
130
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
| $1K | ﹤0.01% | +2,294 | New | +$1K |
|